Why it matters
The rule could affect Americans who seek lower-cost medicines from abroad. The supplied report does not specify which medicines or how many people could be affected.
This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.
This event has left the current brief. The summary below describes the stored record; open the original sources for current conditions.
The Trump administration delayed a rule that could complicate Americans’ access to lower-cost medicines imported from Canada and other countries until after the midterm elections, according to KFF Health News. The article does not say when the rule will take effect after that delay.
HOW THIS BRIEF WAS MADE 1 outlet: 1 national. Automated sourcing and summaries by the BLUF engine. Corrections
The rule could affect Americans who seek lower-cost medicines from abroad. The supplied report does not specify which medicines or how many people could be affected.